These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6891235)

  • 21. Clinical experience with cyclandelate in insulin-dependent diabetic patients with neuropathy.
    De Leeuw IH; Van Rooy P; Moeremans M; Driessens M
    Drugs; 1987; 33 Suppl 2():125-30. PubMed ID: 3304951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclandelate in the treatment of senile mental changes: a double-blind evaluation.
    Rao DB; Georgiev EL; Paul PD; Guzman AB
    J Am Geriatr Soc; 1977 Dec; 25(12):548-51. PubMed ID: 336670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multifocal infarct dementia treated by cyclandelate and monitored by quantitative EEG.
    Harding GF; Hall P; Young J; Smith GA
    Angiology; 1978 Feb; 29(2):139-40. PubMed ID: 347986
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of cyclandelate in depressed and demented patients: a controlled study in psychogeriatric patients.
    Davies G; Hamilton S; Hendrickson E; Levy R; Post F
    Age Ageing; 1977 Aug; 6(3):156-62. PubMed ID: 331919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclandelate in the treatment of multi-infarct dementia. Interim findings from a multicentre study in general practice.
    Blakemore CB
    Drugs; 1987; 33 Suppl 2():110-3. PubMed ID: 3622304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study.
    Gerber WD; Schellenberg R; Thom M; Haufe C; Bölsche F; Wedekind W; Niederberger U; Soyka D
    Funct Neurol; 1995; 10(1):27-35. PubMed ID: 7649498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experiences with a hexobendine combination preparation].
    Engel K; Pramer I; Fischer M
    Wien Klin Wochenschr; 1973 Jan; 85(2):29-30. PubMed ID: 4569038
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclandelate in diabetic radiculoneuropathy.
    van der Drift JH
    Ann Neurol; 1980 Apr; 7(4):388. PubMed ID: 7377764
    [No Abstract]   [Full Text] [Related]  

  • 29. The anti-hypoxaemic effect of cyclandelate in man measured in human volunteers using computer-assisted oculodynamic methodology.
    Schaffler K
    Br J Clin Pract Suppl; 1984; 34():51-7. PubMed ID: 6430324
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyclandelate in the treatment of senility: a controlled study.
    Capote B; Parikh N
    J Am Geriatr Soc; 1978 Aug; 26(8):360-2. PubMed ID: 353121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of early diabetic retinopathy with cyclandelate.
    Cunha-Vaz JG; Reis Fonseca J; Hagenouw JR
    Br J Ophthalmol; 1977 Jun; 61(6):399-404. PubMed ID: 326306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Controlled clinical study of Novodil in the treatment of senile macular lesions].
    Delafoulhouje C; Dalens H; Solé P
    Bull Soc Ophtalmol Fr; 1985 Oct; 85(10):1065-7. PubMed ID: 3915881
    [No Abstract]   [Full Text] [Related]  

  • 33. [Human pharmacokinetics of theophylline and etofylline from different formulations of a cardiotonic (author's transl)].
    Erking W; Lücker PW; Niebch G; Thiemer K; Wetzelsberger K
    Arzneimittelforschung; 1981; 31(2):371-9. PubMed ID: 7194656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of cerebrovascular insufficiency. A psychometric double-blind trial with a slow-release form of xantinol nicotinate (author's transl)].
    Brückner GW; Jansen W
    MMW Munch Med Wochenschr; 1979 Jun; 121(25):861-4. PubMed ID: 111104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combined therapy using actovegin and instenon in encephalopathies of different origins].
    Rumiantseva SA; Gridchik IE; Vrublevskiĭ OP
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(4):46-51. PubMed ID: 7856378
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes in the parameter of asymmetry of EEG wave fronts in patients with cerebral circulatory disorders treated with instenon].
    Lebedeva NV; Makarova GV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(11):1619-24. PubMed ID: 1243214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of cyclandelate on psychological test performance in patients with cerebral vascular insufficiency.
    Smith WL; Lowrey JB; Davis JA
    Curr Ther Res Clin Exp; 1968 Dec; 10(12):613-8. PubMed ID: 4972756
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclandelate and mental functions: a double-blind cross-over trial in normal elderly subjects.
    Judge TG; Urquhart A; Blakemore CB
    Age Ageing; 1973 May; 2(2):121-4. PubMed ID: 4591604
    [No Abstract]   [Full Text] [Related]  

  • 39. [Indications for and effects of vasodilating agents, especially in cerebral and peripheral vascular sclerosis].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1981 Feb; 125(6):228-34. PubMed ID: 7207673
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of sulfocamphocaine on the systemic and cerebral hemodynamics of patients with chronic cerebral circulatory failure].
    Ishchenko MM; Shkrobot SI
    Vrach Delo; 1984 Jul; (7):68-70. PubMed ID: 6475025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.